Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
SMAP1
REST API REST API
Homo sapiens
SMAP1 is differentially expressed in 235 experiments: 93 organism parts: amygdala, brain, ... (91 more);, 135 disease states: normal, Crohn's disease, ... (133 more);, 67 cell types 299 cell lines 28 compound treatments and 66 other conditions.
Synonyms FLJ13159, SMAP-1
Orthologs SMAP1 (Gallus gallus)   Smap1 (Mus musculus)   smap1 (Danio rerio)   AGE2 (Saccharomyces cerevisiae)   SMAP1 (Bos taurus)   smap1 (Xenopus laevis)   A1EAA2_CANFA (Canis familiaris)   (Compare orthologs)
Gene Ontology Term plasma membrane, metal ion binding, regulation of ARF GTPase activity, ARF GTPase activator activity, zinc ion binding, positive regulation of erythrocyte differentiation
InterPro Term ArfGAP
UniProt Accession Q8IYB5, Q5SYQ3, Q5T6I8, E7ETU6, E9PEY8
Search EB-eye ENSG00000112305
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-803, E-GEOD-15765, E-AFMX-5, E-GEOD-6573, E-MEXP-1251, ... (22 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-17482, E-GEOD-5258, E-GEOD-4525, E-MEXP-1006, E-GEOD-19639, ... (33 experiments)

Factor Value U/D Experiments
MCF-10A
2
E-GEOD-14990, E-TABM-420
T47D
2
E-MTAB-62, E-MEXP-440
T84
2
E-MTAB-37, E-GEOD-1474
NCIH2170
1
E-MTAB-37
BE2C
1
E-MTAB-37
CHP212
1
E-MTAB-37
293 more value(s).


Cell type

studied in E-GEOD-22373, E-GEOD-19397, E-GEOD-21668, E-GEOD-3920, E-MEXP-750, ... (31 experiments)

Factor Value U/D Experiments
fibroblast
2
E-GEOD-3920, E-GEOD-3204
memory B cell
2
E-TABM-702, E-MEXP-2360
CD56+ NK cells
2
E-AFMX-5, E-TABM-145
secretory cell
1
E-GEOD-3998
CXCR4 negative
1
E-GEOD-15893
mononuclear cell
1
E-GEOD-6053
61 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-6872, E-GEOD-15960, E-GEOD-1869, E-GEOD-1577, ... (44 experiments)

Factor Value U/D Experiments
adrenocortical carcinoma
2
E-TABM-311, E-GEOD-10927
control
2
E-GEOD-21912, E-GEOD-20295
n/a
1
E-GEOD-19743
congestive cardiomyopathy
1
E-GEOD-1145
colorectal carcinoma
1
E-GEOD-23878
bone tumor
1
E-MTAB-62
129 more value(s).


Compound treatment

studied in E-GEOD-5258, E-GEOD-15205, E-GEOD-1417, E-GEOD-5741, E-TABM-782, ... (16 experiments)

Factor Value U/D Experiments
ox-LDL
1
E-GEOD-5741
5-aza-2'-deoxycytidine
2
1
E-MEXP-1269
5-aza-2'-deoxycytidine + trichostatin A
1
1
E-MEXP-1269
camptothecin
1
E-GEOD-1417
ethanol
1
E-GEOD-3113
unknown
1
E-GEOD-7307
22 more value(s).


Agent

studied in E-GEOD-19519

Factor Value U/D Experiments
DMSO
1
E-GEOD-19519
tunicamycin
1
E-GEOD-19519


Biosource provider
studied in E-MTAB-37, E-GEOD-20559

BioSourceProvider
studied in E-GEOD-19519, E-GEOD-19480

Blood/non-blood meta-groups
studied in E-MTAB-62

Bmngrd
studied in E-GEOD-20194, E-GEOD-16716

Cellular component
studied in E-GEOD-1400

Chromosomal aberration
studied in E-TABM-125

Clinical history
studied in E-GEOD-22097, E-GEOD-19743, E-GEOD-7967, E-TABM-125, E-GEOD-21374, ... (7 experiments)

Clinical info
studied in E-MTAB-37, E-GEOD-6710, E-MEXP-1251, E-GEOD-2034, E-GEOD-21589, ... (7 experiments)

Clinical treatment
studied in E-GEOD-1743, E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

development stage
studied in E-GEOD-22601

Developmental stage
studied in E-MEXP-2359, E-GEOD-4667, E-MTAB-62

dfs time (months)
studied in E-GEOD-21653

Disease staging
studied in E-GEOD-19743, E-TABM-147, E-GEOD-21138, E-GEOD-3013

Environmental stress
studied in E-GEOD-1643, E-GEOD-1518, E-GEOD-3720

Er
studied in E-GEOD-20194, E-GEOD-16716

Estrogen receptor status
studied in E-GEOD-6532

Ethnic group
studied in E-GEOD-20194, E-GEOD-16716

family id
studied in E-GEOD-19519

Genetic modification
studied in E-GEOD-8023, E-MTAB-73, E-GEOD-4025, E-MEXP-1482, E-GEOD-7578, ... (6 experiments)

Genotype
studied in E-GEOD-22056, E-GEOD-3494, E-GEOD-17476, E-GEOD-22593, E-TABM-43, ... (8 experiments)

369 groups
studied in E-MTAB-62

4 groups from blood to incompletely diff
studied in E-MTAB-62

96 groups
studied in E-MTAB-62

Growth condition
studied in E-TABM-263, E-GEOD-5681, E-GEOD-7011, E-GEOD-20540, E-GEOD-9764, ... (6 experiments)

Her2 ihc
studied in E-GEOD-20194, E-GEOD-16716

Histology
studied in E-GEOD-21653, E-TABM-276

Individual
studied in E-MTAB-197, E-TABM-325, E-GEOD-1926, E-MEXP-2069, E-GEOD-16363, ... (27 experiments)

Infection
studied in E-MEXP-1274, E-GEOD-2405, E-GEOD-12254

Karyotype
studied in E-GEOD-7214

Labeling
studied in E-LGCL-5

Material type
studied in E-MEXP-455, E-GEOD-9171

15 meta groups
studied in E-MTAB-62

4 meta groups
studied in E-MTAB-62

6 meta groups
studied in E-MTAB-62

Molecular subtype
studied in E-GEOD-21653

Nbefore
studied in E-GEOD-20194, E-GEOD-16716

Observation
studied in E-TABM-276

organ
studied in E-GEOD-24283

Organism
studied in E-GEOD-1801, E-TABM-84

Organism status
studied in E-GEOD-19188

Pcr vs rd
studied in E-GEOD-20194, E-GEOD-16716

Phenotype
studied in E-GEOD-26495, E-GEOD-19703, E-GEOD-1309, E-GEOD-22309, E-GEOD-1460, ... (6 experiments)

Population
studied in E-GEOD-4922, E-GEOD-4342

Progesterone receptor status
studied in E-GEOD-6532

Protocol type
studied in E-GEOD-22097, E-GEOD-3254, E-GEOD-21837, E-GEOD-19445, E-GEOD-19246 ... (5 experiments)

pt
studied in E-GEOD-21653

Replicate
studied in E-GEOD-10896

RNAi
studied in E-MEXP-2115, E-MEXP-1509, E-MEXP-101, E-GEOD-3697, E-MEXP-1857 ... (5 experiments)

Sample preparation
studied in E-GEOD-16728

sample status
studied in E-GEOD-30573

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-19743, E-GEOD-21374

Sex
studied in E-GEOD-1643, E-GEOD-7307

Stimulation
studied in E-GEOD-20114, E-GEOD-11428

Strain or line
studied in E-MEXP-1996

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-3494, E-GEOD-19188

Tbefore
studied in E-GEOD-20194, E-GEOD-16716

Test result
studied in E-GEOD-1926, E-TABM-276

Translocation cyclin group
studied in E-GEOD-2912

Treatment
studied in E-GEOD-16837, E-MEXP-973, E-GEOD-19246, E-GEOD-19815

Treatment code
studied in E-GEOD-20194, E-GEOD-16716

Tumor grading
studied in E-GEOD-1561, E-GEOD-4922

Vehicle
studied in E-GEOD-5258

Processing time: 0.411 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM